Waiting for AstraZeneca to move
https://www.fool.com/investing/general/2009/05/21/the-astrazeneca-dilemma.aspx
Well, there isn't much left to buy in the market. Large to mid cap cancer players have all disappeared.
Astra is too big to be swallowed and will continue the small acquisition strategy. Which makes better sense than mega merger synergy not mergers.
If pipeline is your problem, buy pipeline.
If pipeline is your problem, don't buy sales and cut cost you end up not solving the problem but patching it.
TLN is comparable to current top M&A target. Totally ignored by the market for no good reason. You want Warburg drug and KRAS drug?
Let's close this strategic review... and announced the bidder and price!